Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.
“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.
New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.
The software was trained using more than 700 images and achieved a breast density classification accuracy of 89%, experts recently shared in Radiology: Artificial Intelligence.
Women with breast arterial calcifications are 51% more likely to develop heart disease or have a stroke, experts explained recently in Circulation: Cardiovascular Imaging.
In an exclusive video, Stacey Wolfson, MD, and Beatriu Reig, MD, MPH, from the NYU Grossman School of Medicine, discuss the findings of their new analysis.
There are not yet consensus-based guidelines available for screening women with dense breast tissue, so researchers at Mayo Clinic recently developed a set of recommendations regarding supplemental screening.
The analysis examined 620 cancer imaging studies from the top 25 imaging-related journals to come up with publication-to-incidence and publication-to-mortality ratios.
The latest U.S. Food and Drug Administration data on mammography systems installed nationwide shows DBT systems are rapidly replacing traditional 2D full field digital mammography units.